Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial. [electronic resource]
Producer: 20201221Description: e012797 p. digitalISSN:- 2047-9980
- Acute Coronary Syndrome -- blood
- Aged
- Biomarkers -- blood
- Blood Proteins
- Diabetes Mellitus, Type 2 -- blood
- Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
- Double-Blind Method
- Female
- Galectin 3 -- blood
- Galectins
- Growth Differentiation Factor 15 -- blood
- Heart Disease Risk Factors
- Heart Failure -- etiology
- Hospitalization
- Humans
- Male
- Middle Aged
- Natriuretic Peptide, Brain -- blood
- Peptide Fragments -- blood
- Piperidines -- therapeutic use
- Prognosis
- Risk Assessment
- Troponin I -- blood
- Uracil -- analogs & derivatives
No physical items for this record
Publication Type: Equivalence Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.